Literature DB >> 23748511

Restless legs syndrome: a review of diagnosis and management in primary care.

Richard K Bogan1, James A Cheray.   

Abstract

Restless legs syndrome (RLS) is a common neurological disorder that is characterized by an urge to move the legs (or arms), usually accompanied by uncomfortable and bothersome sensations in the affected limbs. The prevalence of RLS ranges from 7.2% to 11.5% in the general population, and its symptoms are frequent or severe enough to require medical treatment by approximately 3% of the population. However, RLS remains largely undiagnosed, perhaps due to a lack of understanding of RLS as a medically significant disorder. Restless legs syndrome can have serious clinical consequences and a significant impact on patients' quality of life, and therefore correct diagnosis and appropriate management are important. The symptoms of RLS can be managed effectively by treatment. In this review article, we provide a description of RLS and the 4 diagnostic criteria, including a discussion of differentiating symptoms and other medical conditions that mimic RLS. We review the evidence regarding the clinical impact of RLS on sleep disturbance, patients' overall health and quality of life, and the disorder's association with cardiovascular risk. The current focus of RLS therapy is to provide symptom relief; we discuss the available pharmacologic treatment options for RLS, with a focus on the clinical evidence surrounding non-ergot-derived dopamine receptor agonists, which are the current agents of choice for moderate-to-severe RLS. Finally, we consider when it may be most appropriate for the primary care physician to refer a patient with RLS to a specialist.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23748511     DOI: 10.3810/pgm.2013.05.2636

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  7 in total

Review 1.  Caenorhabditis elegans and its applicability to studies on restless legs syndrome.

Authors:  Pan Chen; Omamuyovwi Meashack Ijomone; Kun He Lee; Michael Aschner
Journal:  Adv Pharmacol       Date:  2019-03-14

2.  A 68-year-old woman with sleep-onset insomnia.

Authors:  Norman Wolkove; Marc Baltzan
Journal:  CMAJ       Date:  2013-09-23       Impact factor: 8.262

3.  The relationship between sleep disorders, anxiety, depression, and cognitive function with restless legs syndrome (RLS) in the elderly.

Authors:  Yuan Xu; Hongbin Wen; Jie Li; Jing Yang; Kai Luo; Liying Chang
Journal:  Sleep Breath       Date:  2021-08-26       Impact factor: 2.655

Review 4.  Efficacy of Pramipexole for the Treatment of Primary Restless Leg Syndrome: A Systematic Review and Meta-analysis of Randomized Clinical Trials.

Authors:  Guang Jian Liu; Lang Wu; Song Lin Wang; Li Li Xu; Li Ying Chang; Yun Fu Wang
Journal:  Clin Ther       Date:  2015-11-11       Impact factor: 3.393

5.  Large genome-wide association study identifies three novel risk variants for restless legs syndrome.

Authors:  Maria Didriksen; Muhammad Sulaman Nawaz; Joseph Dowsett; Steven Bell; Christian Erikstrup; Ole B Pedersen; Erik Sørensen; Poul J Jennum; Kristoffer S Burgdorf; Brendan Burchell; Adam S Butterworth; Nicole Soranzo; David B Rye; Lynn Marie Trotti; Prabhjyot Saini; Lilja Stefansdottir; Sigurdur H Magnusson; Gudmar Thorleifsson; Thordur Sigmundsson; Albert P Sigurdsson; Katja Van Den Hurk; Franke Quee; Michael W T Tanck; Willem H Ouwehand; David J Roberts; Eric J Earley; Michael P Busch; Alan E Mast; Grier P Page; John Danesh; Emanuele Di Angelantonio; Hreinn Stefansson; Henrik Ullum; Kari Stefansson
Journal:  Commun Biol       Date:  2020-11-25

6.  Prevalence of restless legs syndrome in people with diabetes mellitus: A pooling analysis of observational studies.

Authors:  Pingping Ning; Xin Mu; Xinglong Yang; Tian Li; Yanming Xu
Journal:  EClinicalMedicine       Date:  2022-03-24

7.  Correlation between vitamin D and poor sleep status in restless legs syndrome.

Authors:  Chaofan Geng; Zhenzhen Yang; Xiumei Kong; Pengfei Xu; Hongju Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-15       Impact factor: 6.055

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.